Your current location is：{Current column} >>Text
U.S. FDA advisers weigh Pfizer/BioNTech COVID
{Current column}8894People have watched
IntroductionStatement: The content of this article does n ...
Statement: The metatrader4 Android mobilecontent of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Tags：
Related articles
Republican hopefuls woo evangelicals in Iowa, vow to restrict abortion By Reuters
{Current column}By Nathan LayneCLIVE, Iowa (Reuters) -Donald Trump and other Republican presidential hopefuls called ...
Read moreGold stocks plunged as rate cut hopes faded and Goldman warned of a stronger dollar.
{Current column}On January 13, gold stocks plunged significantly, with most major gold stocks falling. At the time o ...
Read moreBitcoin boom drove MicroStrategy's stock up sevenfold past $100 billion, but risks remain.
{Current column}MicroStrategy (MSTR.US) has been a market focal point this year, with its stock price soaring due to ...
Read more
Popular Articles
- Stock market today: Dow closes slightly lower as energy, Intel slump weigh By
- Tesla rose 8%, NVIDIA ended losses, Meta boosts efficiency with layoffs amid AI boom.
- BlackRock recommends overweighting U.S. equities, focusing on cyclical stocks and bond risks.
- Japan and Australia stocks rise, tech rebound lifts U.S. equities.
- Debt limit progress, weak Chinese data
- NVIDIA enters correction, Broadcom hits record high, highlighting chip stock divergence.
Latest articles
-
High activity spotted at North Korea nuclear complex after Kim's bomb
-
The three major indices were mixed, Bitcoin hit a record high, and Nvidia fell 5% post
-
ChiNext down 1%, retail leads as semiconductors, gaming struggle.
-
The U.S. stock market showed mixed movements as the market focused on non
-
4 High Dividend Stocks With Impressive Cash Flow
-
US stocks climbed, with the Dow gaining 300+ points, as ISM data raised rate cut expectations.